Suppr超能文献

连接造血干细胞和成熟巨核细胞的单能巨核细胞生成途径。

Unipotent Megakaryopoietic Pathway Bridging Hematopoietic Stem Cells and Mature Megakaryocytes.

作者信息

Nishikii Hidekazu, Kanazawa Yosuke, Umemoto Terumasa, Goltsev Yury, Matsuzaki Yu, Matsushita Kenji, Yamato Masayuki, Nolan Garry P, Negrin Robert, Chiba Shigeru

机构信息

Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.

Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan.

出版信息

Stem Cells. 2015 Jul;33(7):2196-207. doi: 10.1002/stem.1985. Epub 2015 Apr 27.

Abstract

Recent identification of platelet/megakaryocyte-biased hematopoietic stem/repopulating cells requires revision of the intermediate pathway for megakaryopoiesis. Here, we show a unipotent megakaryopoietic pathway bypassing the bipotent megakaryocyte/erythroid progenitors (biEMPs). Cells purified from mouse bone marrow by CD42b (GPIbα) marking were demonstrated to be unipotent megakaryocytic progenitors (MKPs) by culture and transplantation. A subpopulation of freshly isolated CD41(+) cells in the lineage Sca1(+) cKit(+) (LSK) fraction (subCD41(+) LSK) differentiated only into MKP and mature megakaryocytes in culture. Although CD41(+) LSK cells as a whole were capable of differentiating into all myeloid and lymphoid cells in vivo, they produced unipotent MKP, mature megakaryocytes, and platelets in vitro and in vivo much more efficiently than Flt3(+) CD41(-) LSK cells, especially at the early phase after transplantation. In single cell polymerase chain reaction and thrombopoietin (TPO) signaling analyses, the MKP and a fraction of CD41(+) LSK, but not the biEMP, showed the similarities in mRNA expression profile and visible TPO-mediated phosphorylation. On increased demand of platelet production after 5-FU treatment, a part of CD41(+) LSK population expressed CD42b on the surface, and 90% of them showed unipotent megakaryopoietic capacity in single cell culture and predominantly produced platelets in vivo at the early phase after transplantation. These results suggest that the CD41(+) CD42b(+) LSK are straightforward progenies of megakaryocytes/platelet-biased stem/repopulating cells, but not progenies of biEMP. Consequently, we show a unipotent/highly biased megakaryopoietic pathway interconnecting stem/repopulating cells and mature megakaryocytes, the one that may play physiologic roles especially in emergency megakaryopoiesis.

摘要

最近对血小板/巨核细胞偏向性造血干细胞/再填充细胞的鉴定需要对巨核细胞生成的中间途径进行修订。在此,我们展示了一条绕过双能巨核细胞/红系祖细胞(biEMP)的单能巨核细胞生成途径。通过CD42b(糖蛋白Ibα)标记从小鼠骨髓中纯化的细胞,经培养和移植证明是单能巨核细胞祖细胞(MKP)。谱系Sca1(+) cKit(+)(LSK)组分中新鲜分离的CD41(+)细胞亚群(subCD41(+) LSK)在培养中仅分化为MKP和成熟巨核细胞。尽管CD41(+) LSK细胞整体在体内能够分化为所有髓系和淋巴细胞,但它们在体外和体内产生单能MKP、成熟巨核细胞和血小板的效率比Flt3(+) CD41(-) LSK细胞高得多,尤其是在移植后的早期阶段。在单细胞聚合酶链反应和血小板生成素(TPO)信号分析中,MKP和一部分CD41(+) LSK,而非biEMP,在mRNA表达谱和可见的TPO介导的磷酸化方面表现出相似性。在5-氟尿嘧啶处理后血小板生成需求增加时,一部分CD41(+) LSK群体在表面表达CD42b,其中90%在单细胞培养中表现出单能巨核细胞生成能力,并且在移植后的早期阶段在体内主要产生血小板。这些结果表明,CD41(+) CD42b(+) LSK是巨核细胞/血小板偏向性干细胞/再填充细胞的直接后代,而非biEMP的后代。因此,我们展示了一条连接干细胞/再填充细胞和成熟巨核细胞的单能/高度偏向性巨核细胞生成途径,该途径可能尤其在紧急巨核细胞生成中发挥生理作用。

相似文献

5
Identification of unipotent megakaryocyte progenitors in human hematopoiesis.鉴定人类造血中的单能巨核细胞祖细胞。
Blood. 2017 Jun 22;129(25):3332-3343. doi: 10.1182/blood-2016-09-741611. Epub 2017 Mar 23.
7
CD45 expression discriminates waves of embryonic megakaryocytes in the mouse.CD45 表达可区分小鼠胚胎巨核细胞的波。
Haematologica. 2019 Sep;104(9):1853-1865. doi: 10.3324/haematol.2018.192559. Epub 2018 Dec 20.

引用本文的文献

7
Genetics of inherited thrombocytopenias.遗传性血小板减少症的遗传学。
Blood. 2022 Jun 2;139(22):3264-3277. doi: 10.1182/blood.2020009300.
9
CD62L expression level determines the cell fate of myeloid progenitors.CD62L 表达水平决定了髓系祖细胞的细胞命运。
Stem Cell Reports. 2021 Dec 14;16(12):2871-2886. doi: 10.1016/j.stemcr.2021.10.012. Epub 2021 Nov 18.

本文引用的文献

2
Thrombopoietin from beginning to end.从开始到结束的血小板生成素。
Br J Haematol. 2014 Apr;165(2):259-68. doi: 10.1111/bjh.12772. Epub 2014 Feb 6.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验